Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Oxidative Medicine and Cellular Longevity|July 27, 2017
Role of Kallistatin Treatment in Aging and Cancer by Modulating miR-34a and miR-21 ExpressionJulie Chao, Youming Guo, Pengfei Li, et al.
Biological Chemistry|June 28, 2006
The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reductionJulie Chao, Grant Bledsoe, Hang Yin, et al.
Oxidative Medicine and Cellular Longevity|February 2, 2018
Opposing Effects of Oxygen Regulation on Kallistatin Expression: Kallistatin as a Novel Mediator of Oxygen-Induced HIF-1-eNOS-NO PathwayJulie Chao, Youming Guo, Pengfei Li, et al.
American Journal of Physiology. Renal Physiology|May 25, 2012
Tissue kallikrein activation of the epithelial Na channelAnkit B Patel, Julie Chao, Lawrence G Palmer
American Journal of Physiology. Cell Physiology|May 8, 2003
Structural elements of kallistatin required for inhibition of angiogenesisRobert Q Miao, Vincent Chen, Lee Chao, et al.
Biological Chemistry|July 17, 2008
Tissue kallikrein and kinin infusion promotes neovascularization in limb ischemiaRobert S Smith, Lin Gao, Lee Chao, et al.
Blood|October 18, 2002
Kallistatin is a new inhibitor of angiogenesis and tumor growthRobert Q Miao, Jun Agata, Lee Chao, et al.
American Journal of Physiology. Renal Physiology|May 12, 2005
Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive ratsChun-Fang Xia, Grant Bledsoe, Lee Chao, et al.
Regulatory Peptides|April 2, 2003
Adrenomedullin gene delivery inhibits neointima formation in rat artery after balloon angioplastyJun Agata, Jenny J Zhang, Julie Chao, et al.
Hypertension (Dallas, Tex. : 1979)|June 23, 2010
Kallistatin inhibits vascular inflammation by antagonizing tumor necrosis factor-alpha-induced nuclear factor kappaB activationHang Yin, Lin Gao, Bo Shen, et al.
Pageof 11